ArticleBMC immunology2021

Cisplatin-based chemoradiation decreases telomerase-specific CD4 TH1 response but increases immune suppressive cells in peripheral blood.

Jihane Boustani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.